FOLR2 and ovarian carcinoma: Ovarian cancer (OV) epithelial cells with HMOX1 inhibition could secrete TGF-β1 to activate three macrophage subtypes: SPP1 + , FOLR2 + , and C1QC + via the PI3K/AKT/NF-κB (p65) pathway.